je.st
news
Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel
2014-01-15 00:47:09| Food - Topix.net
The third time may not be the charm. Twice before the FDA has turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson's Xarelto .
Tags: panel
johnson
battle
faces
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|